Cargando…
The Potential Role of Naltrexone in Borderline Personality Disorder
Objective: Management of borderline personality disorder (BPD) is a difficult challenge due to the complex features of this disorder. This article reviews the use of naltrexone in the treatment of BPD. Method: Published articles and clinical trials were searched in Google Scholar, MedLine, ELSEVIER,...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Psychiatry & Psychology Research Center, Tehran University of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483240/ https://www.ncbi.nlm.nih.gov/pubmed/28659987 |
_version_ | 1783245719647289344 |
---|---|
author | Moghaddas, Azadeh Dianatkhah, Mehrnoush Ghaffari, Saba Ghaeli, Padideh |
author_facet | Moghaddas, Azadeh Dianatkhah, Mehrnoush Ghaffari, Saba Ghaeli, Padideh |
author_sort | Moghaddas, Azadeh |
collection | PubMed |
description | Objective: Management of borderline personality disorder (BPD) is a difficult challenge due to the complex features of this disorder. This article reviews the use of naltrexone in the treatment of BPD. Method: Published articles and clinical trials were searched in Google Scholar, MedLine, ELSEVIER, and Cochrane database of systematic reviews abstracts in English language between 1990 and 2017. Results: Naltrexone (NTX), a nonspecific competitive opiate antagonist, has been noted to be helpful in controlling self-injurious behavior (SIB) and dissociative symptoms in patients with BPD. Conclusion: Further studies should be conducted on the effects of naltrexone to confirm the role of this medication in the treatment of BPD. |
format | Online Article Text |
id | pubmed-5483240 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Psychiatry & Psychology Research Center, Tehran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-54832402017-06-28 The Potential Role of Naltrexone in Borderline Personality Disorder Moghaddas, Azadeh Dianatkhah, Mehrnoush Ghaffari, Saba Ghaeli, Padideh Iran J Psychiatry Short Communication Objective: Management of borderline personality disorder (BPD) is a difficult challenge due to the complex features of this disorder. This article reviews the use of naltrexone in the treatment of BPD. Method: Published articles and clinical trials were searched in Google Scholar, MedLine, ELSEVIER, and Cochrane database of systematic reviews abstracts in English language between 1990 and 2017. Results: Naltrexone (NTX), a nonspecific competitive opiate antagonist, has been noted to be helpful in controlling self-injurious behavior (SIB) and dissociative symptoms in patients with BPD. Conclusion: Further studies should be conducted on the effects of naltrexone to confirm the role of this medication in the treatment of BPD. Psychiatry & Psychology Research Center, Tehran University of Medical Sciences 2017-04 /pmc/articles/PMC5483240/ /pubmed/28659987 Text en Copyright © Psychiatry & Psychology Research Center, Tehran University of Medical Sciences This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Communication Moghaddas, Azadeh Dianatkhah, Mehrnoush Ghaffari, Saba Ghaeli, Padideh The Potential Role of Naltrexone in Borderline Personality Disorder |
title | The Potential Role of Naltrexone in Borderline Personality Disorder |
title_full | The Potential Role of Naltrexone in Borderline Personality Disorder |
title_fullStr | The Potential Role of Naltrexone in Borderline Personality Disorder |
title_full_unstemmed | The Potential Role of Naltrexone in Borderline Personality Disorder |
title_short | The Potential Role of Naltrexone in Borderline Personality Disorder |
title_sort | potential role of naltrexone in borderline personality disorder |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483240/ https://www.ncbi.nlm.nih.gov/pubmed/28659987 |
work_keys_str_mv | AT moghaddasazadeh thepotentialroleofnaltrexoneinborderlinepersonalitydisorder AT dianatkhahmehrnoush thepotentialroleofnaltrexoneinborderlinepersonalitydisorder AT ghaffarisaba thepotentialroleofnaltrexoneinborderlinepersonalitydisorder AT ghaelipadideh thepotentialroleofnaltrexoneinborderlinepersonalitydisorder AT moghaddasazadeh potentialroleofnaltrexoneinborderlinepersonalitydisorder AT dianatkhahmehrnoush potentialroleofnaltrexoneinborderlinepersonalitydisorder AT ghaffarisaba potentialroleofnaltrexoneinborderlinepersonalitydisorder AT ghaelipadideh potentialroleofnaltrexoneinborderlinepersonalitydisorder |